Sativex® as an add on therapy for spasticity in MS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Sativex® as an add on therapy for spasticity in MS

Postby MSUK » Thu Oct 14, 2010 2:04 am

Image

Almirall, S.A. announced that results from three pivotal clinical studies of Sativex® were presented in a Satellite Symposium at Europe's leading multiple sclerosis conference, the 26th annual congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), which is taking place in Gothenburg, Sweden from 13-16 October.

These Phase III studies, the main results of which were first announced some months ago, provide robust evidence of the long term efficacy of Sativex® (27 mg delta-9-tetrahydrocannabinol and 25 mg cannabidiol) in symptom improvement in patients with moderate to severe spasticity due to multiple sclerosis who have not responded adequately to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy.

These data have in recent months led to the approval of this first-in-class medication in the UK, Canada and Spain (this last country pending pricing and reimbursement conditions).1,2,3... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2184
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service